Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Medical Holdings Co ( (HK:1515) ) just unveiled an announcement.
China Resources Medical Holdings has secured shareholder approval at an extraordinary general meeting for its 2026–2028 pharmaceuticals, medical devices and medical consumables framework agreement with its controlling shareholder China Resources (Holdings) Company Limited. With connected parties and trustee-held scheme shares abstaining, independent shareholders voted overwhelmingly in favour of the ordinary resolution, authorizing directors to implement the framework agreement and its annual caps through 2028, thereby formalizing a key related-party procurement and supply arrangement that underpins the group’s long-term operational and sourcing structure.
The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.00 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.
More about China Resources Medical Holdings Co
China Resources Medical Holdings Company Limited is a Hong Kong-listed healthcare services provider incorporated in the Cayman Islands, operating hospitals and related medical businesses under the China Resources group. Its activities are closely linked with China Resources (Holdings) Company Limited, reflecting an integrated healthcare and pharmaceutical supply chain focus within the broader China Resources conglomerate.
Average Trading Volume: 6,217,160
Current Market Cap: HK$4.35B
For an in-depth examination of 1515 stock, go to TipRanks’ Overview page.